Health Policy
WHO guidelines, EU directives, and Georgian health governance
Nobody Approves a Supplement Before It Is Sold
Supplements are foods, not medicines. No regulator anywhere approves them before sale. What that means for the buyer — and…
Editor's Top Picks
AI Integration and Federal Policy Shape Biotech Industry Outlook at BIO 2026
Artificial intelligence and federal regulatory policy dominated discussions at BIO International Convention 2026 in San Diego. Industry leaders expressed cautious…
Submit Your Paper →
More form Health Policy
NHS Rolls Out AI Tools to 500,000 Staff to Reduce Administrative Burden
NHS England announces AI tool deployment to over 500,000 healthcare workers, potentially freeing up 2…
Gene Therapy Financing Crisis: $2 Million Cures Lack Payment Infrastructure
Gene therapies costing up to $2 million per treatment face critical financing barriers despite proven…
South Africa’s drug regulator strengthens industry partnerships to improve medicine access
SAHPRA implements quarterly stakeholder engagement sessions with pharmaceutical industry leaders to streamline regulatory processes and…
Indigenous-led health research essential for reconciliation in Canada
Canadian researchers emphasize the need for Indigenous-led health research approaches to advance reconciliation and address…
Trump Administration Proposes Rule to Close Medicare Drug Price Negotiation Loophole
Trump administration proposes rule to close Medicare drug price negotiation loophole, potentially affecting 65 million…